Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NovoCure Ltd | Chief Medical Officer | Ordinary Shares | 105K | $1.91M | $18.19 | Mar 4, 2025 | Direct |
NovoCure Ltd | Chief Medical Officer | Stock Options (Right to buy) | 81.5K | $1.48M | $18.19 | Mar 4, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVCR | NovoCure Ltd | Mar 4, 2025 | 2 | $2.48M | 4 | Mar 6, 2025 | Chief Medical Officer |
NVCR | NovoCure Ltd | Feb 27, 2025 | 2 | -$19.8K | 4/A | Mar 3, 2025 | Chief Medical Officer |
NVCR | NovoCure Ltd | Feb 27, 2024 | 2 | $2.11M | 4 | Feb 29, 2024 | Chief Medical Officer |
NVCR | NovoCure Ltd | Jan 2, 2024 | 0 | $0 | 3 | Jan 11, 2024 | Chief Medical Officer |